Alpine Global Management’s G1 Therapeutics GTHX Stock Holding History
Bought
Maintained
Sold
Alpine Global Management's GTHX Position: Q3 2024 in Review
Alpine Global Management sold out of G1 Therapeutics (GTHX) in Q3 2024, closing a stake of 46,728 shares — an estimated $107K sold.
Alpine Global Management first reported a position in GTHX in Q4 2019 and held it in 3 quarters. The position peaked at $417K in Q4 2019. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Alpine Global Management reported no remaining G1 Therapeutics position as of Q3 2024 after selling out during the quarter.
- Alpine Global Management sold 46,728 G1 Therapeutics shares in Q3 2024, an estimated $107K.
- Alpine Global Management first reported a position in G1 Therapeutics in Q4 2019 and held it in 3 quarters.
- Alpine Global Management's G1 Therapeutics position peaked at $417K in Q4 2019.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics as of Q3 2024.
Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.